In last trading session, Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) saw 1,570,181 shares changing hands with its beta currently measuring 1.66. Company’s recent per share price level of $0.69 trading at -$0.06 or -6.71% at ring of the bell on the day assigns it a market valuation of $70.82 Million. That closing price of DFFN’s stock is at a discount of -168.12% from its 52-week high price of $1.85 and is indicating a premium of 46.38% from its 52-week low price of $0.37. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.62 Million shares which gives us an average trading volume of 8.23 Million if we extend that period to 3-months.
For Diffusion Pharmaceuticals Inc. (DFFN), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas none see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.04 in the current quarter.
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) trade information
In the face of being in the red during last session for losing -6.71%, in the last five days DFFN remained trading in the green while hitting it’s week-highest on Friday, Apr 09 when the stock touched $0.8699 price level, adding 20.11% to its value on the day. Diffusion Pharmaceuticals Inc.’s shares saw a change of -12.58% in year-to-date performance and have moved -21.91% in past 5-day. Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) showed a performance of -34.43% in past 30-days. Number of shares sold short was 2.61 Million shares which calculate 0.32 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $2 to the stock, which implies a rise of 189.86% to its current value. Analysts have been projecting $2 as a low price target for the stock while placing it at a high target of $2. It follows that stock’s current price would jump +189.86% in reaching the projected high whereas dropping to the targeted low would mean a loss of 189.86% for stock’s current value.
Diffusion Pharmaceuticals Inc. (DFFN) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 62.1% during past 5 years. In 2021, company’s earnings growth rate is likely to be around 83% while estimates for its earnings growth in next 5 years are of 0%
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN)’s Major holders
Insiders are in possession of 0.13% of company’s total shares while institution are holding 6.56% percent of that, with stock having share float percentage of 6.57%. Investors also watch the number of corporate investors in a company very closely, which is 23 institutions for Diffusion Pharmaceuticals Inc. that are currently holding shares of the company. Renaissance Technologies, LLC is the top institutional holder at DFFN for having 2.83 Million shares of worth $2.25 Million. And as of December 30, 2020, it was holding 2.78% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 830.47 Thousand shares on December 30, 2020. The number of shares represents firm’s hold over 0.81% of outstanding shares, having a total worth of $660.22 Thousand.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of December 30, 2020, the former fund manager was holding 357650 shares of worth $284.33 Thousand or 0.35% of the total outstanding shares. The later fund manager was in possession of 332.7 Thousand shares on February 27, 2021, making its stake of worth around $382.6 Thousand in the company or a holder of 0.33% of company’s stock.